Blog
Marc Puich
Marc Puich
December 30, 2019

Advanced therapy supply chains: lessons from 100 meetings

You can learn a lot in 100 meetings. In 2019, I conducted more than 100 discussions on advanced therapy supply...

November 15, 2019

Eight million pages, the Space Shuttle, and other highlights from BMWS 2019

If you’re producing cell therapy products for 10,000 patients a year, how many release tests will be required? If making...

July 10, 2019

Supply chain management readiness, Part 4: quality risk management

Note: this post is the last of a four-part series on supply chain planning for personalized therapies such as cell...

June 4, 2019

Supply chain management readiness, Part 3: process

(Note: this post is the third part of a four-part series on supply chain planning for personalized therapies such as...

May 15, 2019

Supply chain management readiness, Part 2: operational ecosystem

(Note: this post is the second part of a four-part series on supply chain planning for personalized therapies such as...

April 24, 2019

Supply chain management readiness, Part 1: strategy

There are many critical decisions to be made when moving a large-molecule biologic out of the lab into human trials....